Post : Junior Research Fellow
Project title : “Dual Inhibitors of EGFR and HDAC as Anti-Lung Cancer Agents: Design, Synthesis and Biological Evaluation”.
Project Duration : 3 Years
Emoluments : Rs. 25,000/- per month (Fixed)
Tenure : Initially for ONE year; extendable up to two more years (based on performance)
Qualification
• M.Pharm., M.S. (Pharm.) (Pharmaceutical Chemistry/Medicinal Chemistry) or M.Sc. (specialization in Organic Chemistry), with minimum 55% marks
• GPAT/ NET/ GATE or equivalent qualification for JRF
• M.Pharm., M.S. (Pharm.) (Pharmaceutical Chemistry/Medicinal Chemistry) or M.Sc. (specialization in Organic Chemistry), with minimum 55% marks
• GPAT/ NET/ GATE or equivalent qualification for JRF
Maximum Age Limit
• Below 30 years
• Relaxation in age for SC/ST/OBC/Women and physically handicapped candidates as per rule
• Below 30 years
• Relaxation in age for SC/ST/OBC/Women and physically handicapped candidates as per rule
Principal Investigator:
Dr. Raj Kumar, Associate Professor,
Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, Punjab
Dr. Raj Kumar, Associate Professor,
Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, Punjab
Co-Principal Investigator:
Dr. Sandeep Singh, Assistant Professor,
Department of Human Genetics and Molecular Medicine,
Central University of Punjab, Bathinda, Punjab
Dr. Sandeep Singh, Assistant Professor,
Department of Human Genetics and Molecular Medicine,
Central University of Punjab, Bathinda, Punjab
Date & Time of Interview : 26.12.2018 at 11:00AM
Venue: Department of Pharmaceutical Sciences & Natural Products, Central University of Punjab, City Campus, Mansa Road, Bathinda-151001
Venue: Department of Pharmaceutical Sciences & Natural Products, Central University of Punjab, City Campus, Mansa Road, Bathinda-151001
NOTE: Interested candidates should appear in person directly in the interview with the duly filled prescribed application form. No TA/DA shall be given to attend the interview.
No comments:
Post a Comment